See what’s changing first. Know which accounts matter next.
Fundz catches funding rounds before they’re announced, and acquisitions, new executives, hiring shifts and contract wins as they happen. It weighs them against your ideal customer profile and delivers a ranked shortlist every morning, with the evidence, the reason to reach out and the decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Lifecore
Acquired Company
Lifecore
DelawareDelawareManufacturingBiotechnologyHealth CareManufacturingBiotechnologyHealth CareDescription
On September 27, 2026, Lifecore Biomedical, Inc. entered into an Agreement and Plan of Merger with Lifecore Inc. and Hazel Merger Sub, Inc. The agreement specifies that Hazel Merger Sub will merge with Lifecore Biomedical, resulting in Lifecore Biomedical becoming a wholly owned subsidiary of Lifecore Inc. This strategic move aims to bolster Lifecore's position in the biopharmaceutical market.
Fundz sees it the moment Lifecore makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Lifecore?
Lifecore was acquired by Lifecore, based in Delaware. The deal was reported on September 28, 2026. Lifecore Inc. is a Delaware corporation engaged in biopharmaceutical development. It specializes in the production of complex injectable products and is committed to advancing therapeutic innovation. Lifecore is privately held and operates in Manufacturing.
When did Lifecore acquire Lifecore?
Lifecore's acquisition of Lifecore was reported on September 28, 2026. On September 27, 2026, Lifecore Biomedical, Inc. entered into an Agreement and Plan of Merger with Lifecore Inc. and Hazel Merger Sub, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lifecore do?
Lifecore Inc. is a Delaware corporation engaged in biopharmaceutical development. It specializes in the production of complex injectable products and is committed to advancing therapeutic innovation. It is privately held, operating in Manufacturing, and is based in Delaware.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.